跳至主要内容
临床试验/NCT07743307
NCT07743307Enrolling By Invitation不适用

Examining the Feasibility of Pairing a Diabetes Self-Management Program With Continuous Glucose Monitoring for Adults With Type 2 Diabetes

Northwell Health1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2026年7月31日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
20
试验地点
1
主要终点
Feasibility of the intervention

研究概览

简要总结

The purpose of this study is to determine if combining a virtual diabetes self-management program (DECIDE®) with continuous glucose monitoring (CGM) is practical and well-received by adults with type 2 diabetes. Twenty participants will attend the 9-week, virtual DECIDE Self-Management Program. They will receive CGM sensors to wear during the 22-week study to track their blood sugar. Participants will complete questionnaires at three time points -- at baseline, 1 week after the DECIDE Program ends, and 3 months after the DECIDE Program ends. They will also complete a blood draw to measure hemoglobin A1C at baseline and 3 months after the intervention ends. Additionally, they will complete a brief interview after the program ends to gather insights into participants' experiences with the program. The study aims to examine whether this integrated approach will be both feasible and acceptable, potentially leading to better diabetes management and improved health outcomes.

详细描述

The overall objective of this project is to pilot and evaluate the feasibility and acceptability of an intervention that combines CGM with a virtually delivered, research-tested diabetes self-management program called DECIDE®, delivered over 9 weeks. We will recruit 20 adults with type 2 diabetes who receive care at Northwell Health, the largest healthcare provider in New York state. Participants will receive the 9-week DECIDE Program as well as CGM sensors to wear during the full 22-week study. Participants will be asked to complete questionnaires to assess diabetes distress, health-related problem-solving, diabetes knowledge, and diabetes self-management behaviors at baseline, 1-week post-intervention, and 3-months post-intervention. They will complete a home blood draw at baseline and 3-months post-intervention. And they will complete a qualitative interview at 1-week post-intervention to assess the acceptability of the intervention. Data related to feasibility will be collected throughout (e.g., rates of recruitment and retention, DECIDE session completion, CGM initiation, and CGM maintenance).

The aims of this study are: 1) to determine the feasibility and acceptability of an intervention pairing DECIDE with CGMs and 2) to explore change in diabetes clinical and behavioral factors between the start of the study and 3 months after the intervention ends.

This work will lead to the development of an accessible, acceptable, and usable intervention that has the potential to provide diabetes self-management support virtually, augmented by CGM, to improve diabetes outcomes for people with type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

盲法说明

No masking

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 years or older
  • Diagnosis of type 2 diabetes
  • Suboptimal hemoglobin A1C (8.0% or greater) based on a laboratory result in the past 3 months
  • Access to and capability of using a smart cellular device
  • Smart cellular device compatible with the Freestyle Libre CGM smartphone application
  • Capable of giving informed consent

排除标准

  • Currently using CGM
  • Non-English speaking
  • Unavailable to attend the virtual DECIDE group
  • Unavailable for follow-up
  • Currently pregnant
  • Currently on dialysis

结局指标

主要结局

Feasibility of the intervention

时间窗: These outcomes will be monitored continuously throughout study completion, approximately 6 months

Feasibility will be assessed as identification of the eligible patient population in the EHR, study recruitment and retention rates, DECIDE enrollment and session completion rates, and CGM initiation and maintenance rates.

Acceptability of the intervention

时间窗: 1-week post-intervention

Acceptability will be assessed by brief interviews with the 20 participants to obtain perspectives on the acceptability of the implementation as well as the intervention and its components (DECIDE Program; CGM initiation and engagement).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验